U.S. flag An official website of the United States government
  1. Home
  2. Training and Continuing Education
  3. CDERLearn Training and Education
  1. Training and Continuing Education

CDERLearn Training and Education

Leveraging Health Literacy and Patient Preferences to Reduce Hypoglycemia Events in Patients with Type 2 Diabetes
This free continuing education (CE) course offers healthcare providers valuable information about the key role of health literacy in reducing hypoglycemic events in Type 2 diabetes. November is National Diabetes Awareness Month and an opportunity for healthcare providers to have important conversations with their patients about the challenges they face with diabetes.

FDA's Role in Public HealthNew Online CE Courses: Practitioners’ Guide for Improving Oral Anticoagulant Use
This online course with free Continuing Education (CE) credit offers valuable information to healthcare providers about improving oral anticoagulant use.

The FDA Bad Ad Program and Prescription Drug Promotion
This updated online course with free Continuing Education (CE) credit offers valuable information to healthcare professionals (HCPs) about prescription drug promotion and educates them to recognize and report potentially false or misleading prescription drug promotion to FDA's Office of Prescription Drug Promotion.


CDERLearn in the Center for Drug Evaluation and Research (CDER) offers a variety of learning opportunities for healthcare professionals, industry, consumers, and academia. The goal is to create a body of educational and information modules about human drug regulation and activities. CDERLearn is a way to share FDA expertise in specific subject areas to further instruct the public about the many ways CDER protects and promotes public health.

Education Series

Information Series

Learn more on FDA's Training and Continuing Education webpage.

Some courses have been archived. To view them, please see the FDA Archive.

Resources for You

FDA Continuing Education Programs

Contact Us

Toll Free
(855) 543-3784, or
(301) 796-3400

Human Drug Information
Division of Drug Information (CDER)
Office of Communications
Feedback Form
10001 New Hampshire Avenue
Hillandale Building, 4th Floor
Silver Spring, MD 20993

Back to Top